Test Price
2,800 AED✅ Home Collection Available
SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test (NGS) in UAE | 2800 AED | DHA Compliant
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity | ISO-Certified NGS | VIP Mobile Phlebotomy
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139) employing validated NGS methodology.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation with DHA-licensed Consultant Medical Geneticist (DHA: 9294403).
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test employs high-coverage Next Generation Sequencing to detect pathogenic variants in the entire SCP2 gene, enabling definitive diagnosis of this rare neurometabolic disorder. This focused assay provides deep coverage of both coding and non-coding regions, ensuring capture of all clinically relevant variants while minimizing incidental findings.
| Feature | Our NGS Test (SCP2 Gene) | Alternative (Sanger Sequencing) |
|---|---|---|
| Coverage | Full gene including introns & regulatory regions | Selected coding exons only |
| Analytical Sensitivity | >99.9% | ~95% |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Accreditation | ISO 9001:2015 (INT/EGQ/2509DA/3139) | May vary |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I confirm that this NGS test is essential for establishing a molecular diagnosis of SCP2-related leukoencephalopathy. Results must be interpreted in the context of clinical findings, neuroimaging, and family history. Pre-test genetic counseling is mandatory to ensure informed consent and appropriate test selection.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Important Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician.
If you are taking anticonvulsants, muscle relaxants, or other neuropsychiatric medications, continue as directed. Any adjustments must be supervised by your specialist.
Exclusion Criteria & Emergency Red Flags
- Patients who have not undergone pre-test genetic counseling and pedigree analysis.
- Inadequate clinical documentation of neurological symptoms (hypotonia, dystonia, motor regression).
- Emergency Red Flags: If you experience sudden severe dystonic crisis, respiratory difficulty, or loss of consciousness, seek immediate medical attention at the nearest emergency room.
Patient FAQ & Clinical Guidance
1. Why is the SCP2 gene test preferred over whole exome sequencing for this condition?
Our comprehensive NGS test provides focused coverage of the entire SCP2 gene with high depth, ensuring detection of both coding and non-coding pathogenic variants. This targeted approach delivers faster turnaround time (3–4 weeks) compared to whole exome sequencing, reduces incidental findings, and is specifically validated for this leukoencephalopathy phenotype.
2. Does this test require mandatory pre-test genetic counseling?
Yes, mandatory pre-test genetic counseling with a qualified genetic counselor is required before testing. This session includes pedigree analysis, risk assessment, discussion of possible outcomes, and informed consent. It ensures you understand the implications of the test results for yourself and your family.
3. What should I do if my result is positive?
A positive result confirms SCP2-related leukoencephalopathy with dystonia and motor neuropathy; this necessitates immediate neurology follow-up and family cascade screening. Your DHA-licensed Consultant Medical Geneticist will interpret the result in clinical context and arrange genetic counseling for at-risk relatives.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All personal and genetic data are processed with explicit consent, encrypted in transit and at rest, and retained only for the duration required by law.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Our digital systems comply with strict ICT security protocols for handling electronic medical records and test results.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Clinical genetic testing and patient consent adhere to this law, ensuring accountability and patient safety throughout the testing journey.
Clinical & Logistical Metadata
| Test Name | SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene coverage with intronic regions |
| ICD-10-CM Code | G93.8 (Other specified disorders of brain) |
| LOINC Code | 93333-9 (SCP2 gene full sequencing) |
| DHA Facility License & Laboratory Address | License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians